183 related articles for article (PubMed ID: 38236555)
21. Organomagnesium suppresses inflammation-associated colon carcinogenesis in male Crj: CD-1 mice.
Kuno T; Hatano Y; Tomita H; Hara A; Hirose Y; Hirata A; Mori H; Terasaki M; Masuda S; Tanaka T
Carcinogenesis; 2013 Feb; 34(2):361-9. PubMed ID: 23125223
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
23. Role of the δ-Opioid Receptor in 2 Murine Models of Colitis.
Bobo TR; Fitzpatrick LR; Whitcomb TL; Cooper TK; Raiciulescu S; Smith JP
Comp Med; 2020 Feb; 70(1):25-34. PubMed ID: 31969211
[TBL] [Abstract][Full Text] [Related]
24.
Silveira DSC; Veronez LC; Lopes-Júnior LC; Anatriello E; Brunaldi MO; Pereira-da-Silva G
World J Gastroenterol; 2020 Nov; 26(43):6782-6794. PubMed ID: 33268961
[TBL] [Abstract][Full Text] [Related]
25. Emu Oil and Saireito in combination reduce tumour development and clinical indicators of disease in a mouse model of colitis-associated colorectal cancer.
Chartier LC; Fujino J; Howarth GS; Freysdottir J; Hardardottir I; Mashtoub S
Biomed Pharmacother; 2021 Jun; 138():111478. PubMed ID: 33756155
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel Nrf2 target genes as prognostic biomarkers in colitis-associated colorectal cancer in Nrf2-deficient mice.
Hammad A; Zheng ZH; Gao Y; Namani A; Shi HF; Tang X
Life Sci; 2019 Dec; 238():116968. PubMed ID: 31628914
[TBL] [Abstract][Full Text] [Related]
27. GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.
Li ZW; Sun B; Gong T; Guo S; Zhang J; Wang J; Sugawara A; Jiang M; Yan J; Gurary A; Zheng X; Gao B; Xiao SY; Chen W; Ma C; Farrar C; Zhu C; Chan OTM; Xin C; Winnicki A; Winnicki J; Tang M; Park R; Winnicki M; Diener K; Wang Z; Liu Q; Chu CH; Arter ZL; Yue P; Alpert L; Hui GS; Fei P; Turkson J; Yang W; Wu G; Tao A; Ramos JW; Moisyadi S; Holcombe RF; Jia W; Birnbaumer L; Zhou X; Chu WM
Gastroenterology; 2019 Jun; 156(8):2297-2312. PubMed ID: 30836096
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin E
Kim HB; Kim M; Park YS; Park I; Kim T; Yang SY; Cho CJ; Hwang D; Jung JH; Markowitz SD; Hwang SW; Yang SK; Lim DS; Myung SJ
Gastroenterology; 2017 Feb; 152(3):616-630. PubMed ID: 27864128
[TBL] [Abstract][Full Text] [Related]
29. Adeno-Associated Virus-Mediated Knockdown of Agmatinase Attenuates Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Colorectal Cancer.
Wang DL; Su Q; Qu Q; Li ZL; Liu Z
Hum Gene Ther; 2023 Jun; 34(11-12):518-529. PubMed ID: 36680755
[TBL] [Abstract][Full Text] [Related]
30. Emu oil and grape seed extract reduce tumour burden and disease parameters in murine colitis-associated colorectal cancer.
Chartier LC; Howarth GS; Trinder D; Mashtoub S
Carcinogenesis; 2021 Feb; 42(2):202-209. PubMed ID: 32940671
[TBL] [Abstract][Full Text] [Related]
31. Upregulation of PD-1 follows tumour development in the AOM/DSS model of inflammation-induced colorectal cancer in mice.
Yassin M; Sadowska Z; Djurhuus D; Nielsen B; Tougaard P; Olsen J; Pedersen AE
Immunology; 2019 Sep; 158(1):35-46. PubMed ID: 31429085
[TBL] [Abstract][Full Text] [Related]
32. Colitis-accelerated colorectal cancer and metabolic dysregulation in a mouse model.
Gao Y; Li X; Yang M; Zhao Q; Liu X; Wang G; Lu X; Wu Q; Wu J; Yang Y; Yang Y; Zhang Y
Carcinogenesis; 2013 Aug; 34(8):1861-9. PubMed ID: 23615396
[TBL] [Abstract][Full Text] [Related]
33. The germ-free mice monocolonization with
Lee YP; Chiu CC; Lin TJ; Hung SW; Huang WC; Chiu CF; Huang YT; Chen YH; Chen TH; Chuang HL
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):207-213. PubMed ID: 30706742
[No Abstract] [Full Text] [Related]
34. Mouse Model of Colitis-Associated Colorectal Cancer (CAC): Isolation and Characterization of Mucosal-Associated Lymphoid Cells.
Santiago L; Castro M; Pardo J; Arias M
Methods Mol Biol; 2019; 1884():189-202. PubMed ID: 30465204
[TBL] [Abstract][Full Text] [Related]
35. Sex differences in inflammation correlated with estrogen and estrogen receptor-β levels in azoxymethane/dextran sodium sulfate-induced colitis-associated colorectal cancer mice.
Jang S; Han H; Oh Y; Kim Y
Heliyon; 2024 Mar; 10(6):e28121. PubMed ID: 38545214
[TBL] [Abstract][Full Text] [Related]
36. Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota.
Deng J; Zhao L; Yuan X; Li Y; Shi J; Zhang H; Zhao Y; Han L; Wang H; Yan Y; Zhao H; Wang H; Zou F
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215376
[TBL] [Abstract][Full Text] [Related]
37. Effect of Estradiol in an Azoxymethane/Dextran Sulfate Sodium-Treated Mouse Model of Colorectal Cancer: Implication for Sex Difference in Colorectal Cancer Development.
Son HJ; Sohn SH; Kim N; Lee HN; Lee SM; Nam RH; Park JH; Song CH; Shin E; Na HY; Kim JS; Lee DH; Surh YJ
Cancer Res Treat; 2019 Apr; 51(2):632-648. PubMed ID: 30064198
[TBL] [Abstract][Full Text] [Related]
38. Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice.
Wang Q; Wang K; Wu W; Lv L; Bian X; Yang L; Wang Q; Li Y; Ye J; Fang D; Wu J; Jiang X; Xie J; Lu Y; Li L
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5915-5928. PubMed ID: 32367312
[TBL] [Abstract][Full Text] [Related]
39. Early lesion formation in colorectal carcinogenesis is associated with adiponectin status whereas neoplastic lesions are associated with diet and sex in C57BL/6J mice.
Boddicker RL; Whitley E; Birt DF; Spurlock ME
Nutr Cancer; 2011 Nov; 63(8):1297-306. PubMed ID: 21958077
[TBL] [Abstract][Full Text] [Related]
40. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
